Clinical Trial Update: Efficacy and Safety of Nintedanib Co-administered With Sildenafil in Idiopathic Pulmonary Fibrosis Patients With Advanced Lung Function Impairment [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of nintedanib given with sildenafil in patients with idiopathic pulmonary fibrosis and advanced lung impairmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Nintedanib (nintedanib)
• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2019-01-11